DCF — ANAHEIM REGIONAL MEDICAL CENTER
Enterprise Value: $-377.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-377.7M
Enterprise Value
$-117.0M
PV of Cash Flows
$-260.6M
PV of Terminal Value
$-419.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $163.0M | $-24.9M | -15.0% | $-31.8M | $-28.9M |
| Year 2 | $167.8M | $-23.9M | -14.0% | $-31.0M | $-25.7M |
| Year 3 | $172.9M | $-22.9M | -13.0% | $-30.2M | $-22.7M |
| Year 4 | $178.1M | $-22.7M | -13.0% | $-30.3M | $-20.7M |
| Year 5 | $183.4M | $-23.0M | -13.0% | $-30.7M | $-19.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-377.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$158.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15763638742833197
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5